Skip to content
MS
unreviewed

LDL receptor (LDLR)

0 reactions · 0 pathways

What it does, reaction by reaction

0 reactions

This enzyme appears only in the regulation table, with no catalysed step recorded.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Lipoprotein Metabolism (Exogenous and Endogenous Pathways: chylomicrons, VLDL, LDL, HDL)

Accelerated by

SREBP-2 when hepatocyte cholesterol is low; receptor recycling

Inhibited by

Intracellular cholesterol; PCSK9-mediated degradation

Hormonal control

Insulin can increase expression; statin-mediated cholesterol depletion strongly increases LDLR through SREBP-2

Recent literature

Nothing is fetched until you ask, so the page stays fast and the request is yours rather than automatic.

Europe PMC · ten most recent, newest first